Related Experiment Video
Updated: Aug 2, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Emerging relations between infectious diseases and coronary artery disease and atherosclerosis
1Department of Medicine, St. Michael's Hospital, Toronto, Ont. fongi@smh.toronto.on.ca
Insights
Infectious diseases, like Chlamydia pneumoniae, may contribute to cardiovascular disease (CVD) in some patients. Further research is needed to confirm causality and guide antibiotic therapy for coronary artery disease (CAD).
Area of Science:
- Cardiology
- Infectious Diseases
- Microbiology
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality globally.
- A significant number of coronary artery disease (CAD) patients lack traditional risk factors.
- Infectious agents are increasingly investigated for their potential role in CVD development and progression.
Purpose of the Study:
- To review the current evidence linking infectious diseases to coronary artery disease (CAD).
- To discuss the established association with Chlamydia pneumoniae and controversial links with other pathogens.
- To explore the implications for future therapeutic strategies in managing cardiovascular disease and stroke.
Main Methods:
- Literature review of studies investigating the association between infections and CAD.
- Analysis of data on specific pathogens such as Chlamydia pneumoniae, cytomegalovirus, and Helicobacter pylori.
- Evaluation of evidence regarding infectious agents in restenosis and post-transplant CAD.
Main Results:
- A strong association exists between Chlamydia pneumoniae and CAD, though causality is unproven.
- Cytomegalovirus shows a more significant link to restenosis and post-transplant CAD.
- Evidence for other infections like Helicobacter pylori and periodontitis remains controversial.
Conclusions:
- Infections may play a role in the multifactorial nature of cardiovascular disease.
- Proving causality is crucial before widespread implementation of antibiotic therapy for CAD.
- Ongoing clinical trials are essential to determine the efficacy of antimicrobial treatments for cardiovascular conditions.
Abstract:
Cardiovascular disease is the leading cause of death in developed countries. The cause is multifactorial. A substantial proportion of patients with coronary artery disease (CAD) do not have traditional risk factors. Infectious diseases may play a role in these cases, or they may intensify the effect of other risk factors. The association of CAD and Chlamydia pneumoniae infection is firmly established, but causality is yet to be proven. The link with other infectious agents or conditions, such as cytomegalovirus, herpes simplex virus, Helicobacter pylori and periodontitis, is more controversial. Cytomegalovirus infection is more strongly linked than native CAD to coronary artery restenosis after angioplasty and to accelerated CAD after cardiac transplantation. However, new data on this topic are appearing in the literature almost every month. The potential for novel therapeutic management of cardiovascular disease and stroke is great if infection is proven to cause or accelerate CAD or atherosclerosis. However, physicians should not "jump the gun" and start using antibiotic therapy prematurely for CAD. The results of large randomized clinical trials in progress will help establish causality and the benefits of antimicrobial therapy in CAD.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

